MedTrace Logo

Horyzons: Implementation in Clinical Practice

NCT04673851 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2024-08-15

Study results available
· View outcomes & findings →

Summary

A clinical trial investigating the feasibility and acceptability of implementing a moderated online social media platform with therapeutic content, Horyzons, as a part of care received at first-episode psychosis (FEP) clinics across North Carolina. Clients between the ages of 16 and 35 who are enrolled at one of the 4 FEP clinics or 3 UNC-affiliated STEP Clinics in North Carolina will be considered for enrollment in the trial. Cohort 1 participants will have access to the platform for 3 months and cohort 2 participants will have access to the platform for 6 months. All interventions and assessments will be completed virtually/remotely due to the global pandemic.

Conditions

  • Schizophrenia
  • Schizoaffective Disorder
  • Schizophreniform Disorders
  • Unspecified Schizophrenia Spectrum and Other Psychotic Disorder

Interventions

DEVICE

Horyzons USA

Participants will be oriented to the site (online platform) and how to use it. The site includes curated therapeutic content surrounding issues such as generalized anxiety, social anxiety, social functioning, depression, and distress tolerance. The site also includes a social media function, in which participants and peer support specialists can post text, images, and videos. The site is monitored by graduate students and trained clinicians.

Sponsors & Collaborators

  • North Carolina Department of Health and Human Services

    collaborator OTHER_GOV

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • David Penn, PhD · University of North Carolina, Chapel Hill

  • Diana Perkins, MD, MPH · University of North Carolina, Chapel Hill - School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-19
Primary Completion
2023-08-31
Completion
2023-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04673851 on ClinicalTrials.gov